ES2013500A6 - Metodo para producir una variante de secuencioa de aminoacidos de un activador de plasmionogeno. - Google Patents

Metodo para producir una variante de secuencioa de aminoacidos de un activador de plasmionogeno.

Info

Publication number
ES2013500A6
ES2013500A6 ES8901686A ES8901686A ES2013500A6 ES 2013500 A6 ES2013500 A6 ES 2013500A6 ES 8901686 A ES8901686 A ES 8901686A ES 8901686 A ES8901686 A ES 8901686A ES 2013500 A6 ES2013500 A6 ES 2013500A6
Authority
ES
Spain
Prior art keywords
variants
processes
production
plasminogen activators
glycosylated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES8901686A
Other languages
English (en)
Inventor
Stephen Anderson
Bruce Keyt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of ES2013500A6 publication Critical patent/ES2013500A6/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

METODO PARA PRODUCIR UNA VARIANTE DE SECUENCIA DE AMINOACIDOS DE UN ACTIVADOR DE PLASMINOGENO. SE PREPARA UNA VARIANTE DE SECUENCIA DE AMINOACIDOS FIBRINOLITICAMENTE ACTIVA DE UN ACTIVADOR DE PLASMINOGENO, QUE TIENE UNO O MAS SITIOS QUE NO ESTAN GLICOSILADOS EN LA MOLECULA NATURAL PERO QUE ESTAN GLICOSILADOS EN LA VARIANTE. SE PUEDEN PREPARAR SECUENCIAS DE ADN QUE CODIFICAN LAS VARIANTES, ASI COMO VECTORES DE EXPRESION QUE INCORPORAN LAS SECUENCIAS DE ADN Y CELULAS HOSPEDANTES TRANSFORMADAS CON LOS VECTORES DE EXPRESION. LAS VARIANTES SE PUEDEN UTILIZAR EN UN PREPARADO FARMACEUTICO PARA TRATAR UNA ENFERMEDAD O CONDICION VASCULAR EN PACIENTES.
ES8901686A 1988-05-20 1989-05-19 Metodo para producir una variante de secuencioa de aminoacidos de un activador de plasmionogeno. Expired - Fee Related ES2013500A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19690988A 1988-05-20 1988-05-20

Publications (1)

Publication Number Publication Date
ES2013500A6 true ES2013500A6 (es) 1990-05-01

Family

ID=22727245

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8901686A Expired - Fee Related ES2013500A6 (es) 1988-05-20 1989-05-19 Metodo para producir una variante de secuencioa de aminoacidos de un activador de plasmionogeno.

Country Status (12)

Country Link
EP (1) EP0424405B1 (es)
JP (1) JP2928798B2 (es)
AT (1) ATE111525T1 (es)
AU (1) AU624158B2 (es)
CA (1) CA1341432C (es)
DE (1) DE68918279T2 (es)
DK (1) DK175938B1 (es)
ES (1) ES2013500A6 (es)
HK (1) HK1007333A1 (es)
IL (1) IL90146A (es)
NZ (1) NZ229081A (es)
WO (1) WO1989011531A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5098840A (en) * 1986-07-03 1992-03-24 The Green Cross Corporation Human prourokinase mutants
US5218092A (en) * 1988-09-29 1993-06-08 Kyowa Hakko Kogyo Co., Ltd. Modified granulocyte-colony stimulating factor polypeptide with added carbohydrate chains
HUT52559A (en) * 1988-12-12 1990-07-28 Yamanouchi Pharma Co Ltd Process for production of proteins with trombolitic effect
JPH0387180A (ja) * 1989-05-18 1991-04-11 Green Cross Corp:The 変異ヒトプロウロキナーゼ、その製法、ｄｎａ配列、プラスミド、宿主
US5246850A (en) * 1990-07-31 1993-09-21 Genentech, Inc. DNA molecules encoding human tissue plasminogen activator variants with decreased clearance, vectors, and host cells
WO1992002612A2 (en) * 1990-07-31 1992-02-20 Genentech, Inc. Tissue plasminogen activator variants with decreased clearance
US5242688A (en) * 1990-12-24 1993-09-07 Eli Lilly And Company Method of treating thromboembolic disorders by administration of diglycosylated t-pa variants
US5595736A (en) * 1991-04-22 1997-01-21 Eli Lilly And Company Compounds and methods for treatment of thromboembolic disorders
US5223408A (en) * 1991-07-11 1993-06-29 Genentech, Inc. Method for making variant secreted proteins with altered properties
AU664469B2 (en) * 1992-06-03 1995-11-16 Genentech Inc. Tissue plasminogen activator glycosylation variants with improved therapeutic properties
US5945432A (en) * 1995-12-22 1999-08-31 The University Of Vermont And State Agricultural College Thrombolytic agents and thienopyridine derivatives in acute stroke
US7553930B2 (en) 2003-01-06 2009-06-30 Xencor, Inc. BAFF variants and methods thereof
NZ548513A (en) * 2004-01-14 2010-05-28 Univ Ohio Methods of producing peptides/proteins in plants and peptides/proteins produced thereby

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8528321D0 (en) * 1985-11-18 1985-12-24 Ciba Geigy Ag Modified fibrinolytic agents
AU605124B2 (en) * 1985-12-23 1991-01-10 Behringwerke Aktiengesellschaft Novel peptide plasminogen activators
DK43387A (da) * 1986-01-29 1987-07-30 Beecham Group Plc Fibrinolytisk enzym
AU7090787A (en) * 1986-02-19 1987-10-08 Beecham Group Plc Tissue plasminogen activator
IE81073B1 (en) * 1986-03-18 2000-01-12 Genentech Inc Modified human tissue-type plasminogen activator and its preparation

Also Published As

Publication number Publication date
IL90146A (en) 1994-10-07
EP0424405B1 (en) 1994-09-14
ATE111525T1 (de) 1994-09-15
DE68918279T2 (de) 1995-03-23
JPH03504327A (ja) 1991-09-26
EP0424405A1 (en) 1991-05-02
HK1007333A1 (en) 1999-04-09
AU3744889A (en) 1989-12-12
DE68918279D1 (de) 1994-10-20
DK175938B1 (da) 2005-07-25
AU624158B2 (en) 1992-06-04
CA1341432C (en) 2003-06-17
DK274990A (da) 1991-01-18
DK274990D0 (da) 1990-11-19
NZ229081A (en) 1991-03-26
WO1989011531A1 (en) 1989-11-30
IL90146A0 (en) 1989-12-15
JP2928798B2 (ja) 1999-08-03

Similar Documents

Publication Publication Date Title
ES2013500A6 (es) Metodo para producir una variante de secuencioa de aminoacidos de un activador de plasmionogeno.
EP0259475A4 (en) RECOMBINANT HUMAN ENDOTHEL CELL GROWTH FACTOR.
IL86693A0 (en) Novel proteins with factor viii activity,process for their preparation using genetically engineered cells and pharmaceutical compositions containing them
EP0278696A3 (en) An arg-serpin human plasminogen activator inhibitor designated pai-2
CA2025900A1 (en) Derivative of tissue-type plasminogen activator
ATE69241T1 (de) Herstellung von polypeptiden mit humangammainterferon-aktivitaet.
EP0230945A3 (en) Thrombin-binding substance and process for preparing thethrombin-binding substance and process for preparing the same same
EP0233013A3 (en) Modified enzyme
SE8701921L (sv) Ny farmaceutisk anvendning
FI882605A0 (fi) Menetelmä, jonka avulla voidaan valmistaa suuren spesifisen tilavuusaktiivisuuden omaavaa liuosta proteiinista, jolla on kudosplasminogeeniaktivaattori(t-PA)-aktiivisuutta
KR900002795A (ko) 하이브리드 단백질c 작제물 및 그들의 제조방법
IL90947A (en) Method for production of hiv protease in transformed cells, dna and vectors comprising said dna used in said production
KR900702018A (ko) 단백질과 핵산
NO175541C (no) Fremgangsmåte for fremstilling av human vevtype plasminogenaktivator
DE69113049D1 (de) Varianten des gewebeplasminogenaktivators mit vermindertem abbau.
GR3005408T3 (es)
EP0386240A4 (en) Novel polypeptide compounds
GR3015094T3 (en) Tissue plasminogen activator substitution variant.
NZ229611A (en) A bolus formulation containing at least 12.5 mu of t-pa
KR870008588A (ko) 신규 인체 조직형 플라스미노겐 활성제 폴리펩티드
Rijken et al. 281 Substrate specificity of tissue-type and urokinase-type plasminogen activators
ES2005417A6 (es) Mejoras introducidas en el objeto de la patente principal numero, 551.770 por "un procedimiento para preparar activador de plasminogeno del tipo tejido modificado.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20100315